Shields partners with about 80 U.S. health systems, representing about 1,000 hospitals, to integrate specialty pharmacy services, according to a Sept. 20 news release from Walgreens Boots Alliance.
In September 2021, Walgreens paid Shields $970 million for 71 percent of its shares. The total acquisition is expected to finalize by the end of 2022.
“Our full acquisition of Shields will complete another major milestone as part of our consumer-centric healthcare strategy to drive sustainable long-term growth, and we are very pleased with our partnership and integration with Shields,” Walgreens Boots Alliance CEO Roz Brewer said in the release. “We can now make further progress on our strategy through Shields’ integrated model, increasing our value to health systems, expanding access to payer partners and supporting improved outcomes and lower costs.”
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.